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Abstract: It is a common misconception to view the “cyto”-skeleton as just the filament systems 
in the “cyto”-plasm. In fact, the cytoskeleton extends into the nucleus where the complex network 
connects to chromatin, and it also connects through the plasma membrane to the cytoskeleton 
of adjacent cells and to the “exo”-skeleton of the extracellular matrix. This review will focus 
principally on the subcomplex of the cytoskeleton associated with the nucleus, often referred 
to as the nucleoskeleton, but in the context of its extensive interconnectivity with the rest of the 
nucleus and with cytoplasmic filament systems all the way to the exoskeleton. The nucleoskeleton, 
made principally of type-V intermediate filament lamins, connects across the double membrane 
system of the nuclear envelope to likely all three primary cytoplasmic filament systems. It pro-
vides structural stability to the nucleus, and also incredible flexibility. In both its core structural 
aspect and through specificity gained by tissue-specific partner proteins, it contributes to genome 
organization and regulation as well as to signal transduction, both through chemical signaling 
cascades and likely through mechanotransduction. Defects in the nucleoskeleton have far-ranging 
effects due to its interactions with cytoplasmic filament systems, from mispositioning of nuclei 
to disruption of cell polarity and both decreased and increased cell migration depending on the 
defect. Accordingly, it is not surprising that many nucleoskeletal components are linked to a wide 
range of human diseases from specific types of cancer to muscular dystrophies, neuropathies, 
dermopathies, and premature aging syndromes.
Keywords: nuclear envelope, lamin, LINC complex, cytoskeleton, nuclear envelopathies
Introduction
Cytoskeletal proteins are among the most abundant in any cell. Three principal fila-
ment systems defined by their diameter work together to largely define cell shape 
and stability: microfilaments (7 nm), intermediate filaments (IFs; 10 nm), and 
microtubules (25 nm). Additional meshworks formed by spectrin and nesprin (syne) 
proteins also contribute to these functions. These are supported by roughly 5% of 
all genes encoded in the human genome that contribute to cytoskeletal assembly, 
regulation, and  function. They also direct a variety of more specific functions for 
skeletal elements such as involvement in cytokinesis, pinocytosis, and phagocytosis; 
intracellular transport; signaling pathways; and cell migration.1 Some functions 
and structures are highly tissue-specific such as the Z-bands of muscle, immune 
synapses, actin in the acrosomes of spermatozoa (in lower organisms), cilia, and 
flagella, and many others.1,2
In the context of these myriad functions, the cytoskeleton connects different cel-
lular organelles. Organelles are delimited by membranes and often have some kind 
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of “scaffolding” protein to stabilize their membranes. For 
example, the inner surface of the plasma membrane is lined 
by spectrin filaments, and COP proteins coat the outer surface 
of the endoplasmic reticulum, contributing to its structure as 
much as to vesicle trafficking. The nucleus stands out from 
other organelles because it has the only organelle membrane 
lined on the inside by one of the “big 3” cytoskeletal fila-
ment types – the IFs (Figure 1). The nucleus also stands out 
in having a uniformly spaced double membrane maintained 
by a specialized system that also connects the nucleoskeletal 
IFs across the double membrane to cytoplasmic filament 
systems (Figure 1).
The first nucleoskeletal components were discovered 
roughly 30 years ago,3–6 but our knowledge of this special-
ized cytoskeletal subdomain is poor compared to cytoplasmic 
filament systems. To begin with, the actual structure of the 
nucleoskeletal polymer formed by the type-V IF lamins 
that lines the inner nuclear membrane remains obscure. 
Electron microscopy of the inner nuclear envelope surface 
in freeze-fractured frog oocyte nuclei reveals a network of 
the expected ∼10 nm filaments;7 however, such a structure 
has not been observed in any somatic cell or oocyte from a 
higher vertebrate. This may reflect the tendency for chro-
matin to be highly connected to the inner nuclear membrane 
(except in lower oocytes) such that it obscures the lamin 
filaments, but it is also possible that differences in the milieu 
of nuclear cytoskeletal-associated proteins and the nature of 
lining a membrane surface result in a different structure for 
the polymer.
Although many functions have been ascertained for 
cytoplasmic filament-associated proteins, there are few 
clearly indicated thus far for the nuclear IF lamins. The 
best characterized are the SUN and nesprin families, form-
ing a complex termed the LInker of Nucleoskeleton and 
Cytoskeleton (LINC) complex,8 which spans the double 
membrane and connects the nucleoskeleton to the cytoplas-
mic cytoskeletal filament systems (Figure 1). Both SUN 
and nesprin proteins are nuclear envelope transmembrane 
(NET) proteins. The recent identification of a large number 
of NETs by proteomics9–12 paves the way to determine the 
likely many nuclear-cytoskeletal-associated protein func-
tions. Many NETs are highly tissue-specific,13 thus potentially 
enabling tissue-specific nucleoskeletal functions. Indeed, 
the use of multiple tissue libraries in 2-hybrid studies has 
identified over 600 partners for lamins including many of 
these NETs,14,15 thus increasing the likelihood that they could 
mediate such tissue-specific functions. Although only a small 
subset of identified NETs has been directly tested, nearly all 
those bind both lamins and chromatin,16 thus also connecting 
the genome to the cytoskeleton (Figure 1).
The importance of these many nucleoskeletal functions is 
underscored by the association of many diseases with muta-
tions in nucleoskeletal proteins. More mutations causing dis-
tinct diseases have now been linked to LMNA than any other 
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Figure 1 Schematic of the nuclear envelope.
Notes: The nuclear envelope is a double membrane system with the outer membrane continuous with the endoplasmic reticulum (eR) and both membranes fusing where 
nuclear pore complexes (NPC) are inserted. Nesprin proteins in the outer nuclear membrane (ONM) connect directly or indirectly to the three principal cytoplasmic 
filament systems (from left to right) actin, tubulin, and intermediate filaments (IFs). They also connect to more specialized structures such as on the right side of the NPC 
TAN lines, and other nuclear envelope transmembrane (NET) proteins also appear to have interactions with cytoskeletal filaments (furthest right depiction). The nesprins 
connect in the lumen of the nuclear envelope to SUN proteins in the inner nuclear membrane (iNM). These in turn connect to the iF lamin polymer. Both lamins and other 
NeTs connect to chromatin.
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gene in the human genome.17 Moreover, many NETs have 
also been linked to disease, particularly those involved in the 
LINC complex.18 Interestingly, these diseases are extremely 
wide ranging, including muscular dystrophies, neuropathies, 
lipodystrophies, dermopathy, osteopoikilosis, and multi-
systemic disorders such as the premature aging progeroid 
syndromes.17,19 This makes for a conundrum, because, often, 
mutations in the same widely expressed protein can cause 
multiple diseases with distinct tissue pathologies. Thus, it is 
likely that additionally more tissue-specific nuclear envelope 
proteins are also involved.20
Nuclear versus cytoplasmic  
filament systems
Similar to cytoplasmic filaments, the nucleoskeleton plays a 
central role in nuclear structure and stability. Thus, one might 
assume that the two related and connected systems would 
be similar in organization. Yet, the nucleoskeleton comprises 
just IFs. To understand the logic of this evolutionary choice, 
it is necessary to consider the different properties of the three 
central filament systems (Figure 2A).
Cytoplasmic filament systems
The building blocks for microfilaments (actin) and microtu-
bules (tubulin) are soluble globular proteins that assemble 
into linear arrays (Figure 2B). In contrast, the building blocks 
for IF assembly are poorly soluble because roughly half of 
the protein mass is a series of heptad repeats formed into a 
linear coiled-coil dimer of 48–52 nm length. This increases 
the strength and stability but also renders them less dynamic 
than actin and tubulin that are polarized and dynamically 
assemble and disassemble driven by nucleotide binding 
and hydrolysis. The coiled-coil domain is broken into four 
parts by the linker regions, which may explain in part why 
IFs are also flexible. IF dimers next assemble into multiple 
 head-to-tail linear arrays, which then layer over one another 
in a staggered fashion using interactions from both the coiled 
coils and the globular head and tail domains within and 
between arrays.21,22 The arrays layer like the individual fibers 
of a rope until there are 32 linear arrays/fibers in cross section 
with intermolecular interactions in all directions throughout 
to form a 10-nm filament. This complex structure renders IFs 
less dynamic23,24 and apolar.
These characteristics all contribute to significant differ-
ences in the biophysical behavior of the various filament 
systems under stress. Microfilaments are stabilized by 
tension and tend to resist stretch/strain, but break easily 
under compression forces. Microtubules are more resistant 
to a compression force, but break easily under stretch/strain. 
In contrast, IFs resist both compression and stretch/strain 
forces that tear microfilaments and microtubules apart.25 
Thus, IFs are, at the same time, the most stable, strongest, 
and most elastic of the filament systems.
The filament systems also differ from the standpoint 
of tissue specificity. The three tubulin isoforms are uni-
versal, while actin has one universal isoform and four 
with  specialized/tissue-specific functions such as forming 
Z-bands in the muscle. In contrast, IFs have over 70 distinct 
genes, many encoding multiple splice forms, and all except 
lamins are highly tissue-specific.1 For example, myogenic 
and neuronal precursors both express vimentin, but this is 
replaced by desmin in mature muscle and neurofilaments 
in neurons. Similarly, different layers of epidermis express 
different combinations of keratins. The many tissue-specific 
IFs enable a further diversity of function from their specific 
binding partners.
Nucleoskeleton
Tubulin is absent from the interphase nucleus. Though actin 
enhances the function of some helicases in yeast,26 there is no 
defined pathway for its regulated import and it remains con-
troversial whether this nuclear actin assembles filaments.27 
Although filaments can be forced by overexpressing actin 
carrying nuclear localization signals, it is noteworthy that 
wild-type actin has two conserved nuclear export signals 
to keep the nuclear levels low.28 Moreover, this minor actin 
population is dwarfed by lamins, which are typically  present 
at ∼3 million copies in a typical mammalian nucleus.29 
Thus, actin and tubulin are not likely to contribute to the 
nucleoskeleton, which comprises principally the type-V IF 
lamins. Lamins differ from cytoplasmic IFs principally by 
having a longer coiled-coil region (+6 heptads),30,31 a nuclear 
localization sequence,32,33 and a C-terminal CaaX box that is 
farnesylated.34,35 All three of these differences contribute to 
the translocation of lamins into the nucleus.36,37
There are three genes encoding lamins: LMNA, LMNB1, 
and LMNB2. At least one B-type lamin is expressed in all 
cells, while lamin A is expressed later in differentiation. 
A combination of tissue differences in relative expression 
levels and several splice variants enable tissue specific-
ity for the nucleoskeleton.38–40 The predominant LMNA 
splice variants in order are lamin A, C, A∆10,41 and C2 
that is unique to sperm cells.42 LMNB1 also has a tissue-
specific splice variant, lamin B3,43 and others are yet 
to be identified. All splice variants share the coiled-coil 
domain, which is the most conserved region by sequence. 
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Nonetheless, the coiled coils may differ structurally, as 
prediction algorithms suggest that lamin B2 might have two 
linkers fused into one long one, thus losing one of the four 
coiled coils. This should, in theory, increase flexibility and, 
though point mutations in the linkers did not yield notable 
assembly phenotypes in keratins,44 the lamin B2 was less 
stable in vitro45,46 and in vivo.47,48 Thus, differences in the 
relative expression levels of the different lamin subtypes 
in  different tissues can yield distinct mechanical properties 
to the polymer.
As the lack of chromatin connections in Xenopus oocyte 
nuclei enables visualization of the inner membrane surface,7 
different lamin subtypes were exogenously expressed in this 
system, yielding distinct assemblies.49 This suggests that dif-
ferent lamin subtypes form distinct networks and is further 
supported by immunogold-labeling electron microscopy and 
A
B
Intermediate filaments
Intermediate filaments
Microtubules
Actin
TubulinActin
~7 nm ~10 nm
~25 nm
Figure 2 Cytoskeletal systems.
Notes: (A) The different filament systems are highlighted in a sectored cell. From the top are intermediate filaments (Ifs) in green, microtubules in purple, actin stress fibers 
and lamellipodia in blue, and, finally, all three interacting and functioning together. (B) Comparison of actin, iF, and tubulin skeletal systems from left to right. Top panels are 
the building block subunits used to build the system. Middle panels are the assembled filaments. Bottom panels indicate specialized systems that can separately be built by the 
subunits in context of different associated proteins, muscle fiber Z-bands for actin and flagella for tubulin.
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superresolution studies in certain cell types,50 while other 
studies observed Förster resonbance energy transfer (FRET) 
between different lamin subtypes and these subtypes inter-
acted in vitro.45,51,52 Thus, this issue remains unresolved.
As mentioned above, lamins also differ from cytoplasmic 
IFs in that they are posttranslationally modified with the 
addition of a C-terminal farnesyl lipid moiety. As lamins 
are highly insoluble, association with the membrane through 
this modification could help prevent off-target aggregation 
and thus support proper assembly. At the same time, as both 
nuclear localization sequence and CaaX box contributed to 
lamin targeting,36 lamin association with the membrane might 
enable a backup system for transit through the peripheral 
channels of the NPC, though this has never been tested. 
Finally, this lipid modification may directly link the lamin 
polymer to the membrane to anchor it at the inner nuclear 
surface.53,54 This idea is supported by observations in the 
Xenopus oocyte system where B-type lamins appeared to 
assemble closer to the membrane than lamin A.49 B-type 
lamins keep their farnesyl moiety, while it is only transient 
in lamin A due to subsequent cleavage of several C-terminal 
residues.55 Mutations that prevent the subsequent removal of 
the farnesyl group perturb cells,56 but the functional reason 
for its transient addition in the case of lamin A remains 
obscure.
Network connectivity
The three central filament systems of the cytoplasm are inter-
connected through cytoskeletal-associated proteins. They 
must also be connected to the nucleoskeleton because the 
nucleus was “pulled” in the same direction as cytoplasmic 
filaments in experiments where a pipette tip was applied out-
side the nucleus in the cytoplasm.57 These and other observa-
tions led to the cellular tensegrity model proposed by Donald 
Ingber58 that explains the cytoskeleton as a 3D assembly 
comprises compression-resistant struts (microtubules) con-
nected by stretchable linkers under tension (actin filaments). 
Thus, the cell is more like a tent with poles (compression) and 
anchored ropes (tension) as opposed to a brick and mortar 
structure just under compression stress.
As the nucleoskeleton comprises just the lamin IFs, there 
are apparently no countering forces in the isolated nucleus 
to generate tensegrity, but at the same time, the filaments are 
elastic, deformable, and capable of withstanding strong com-
pression or stretch/tension forces. However, in intact cells this 
elastic nucleoskeleton is connected to the cytoplasmic fila-
ment network with its mixed properties principally through 
the LINC complex.8 The core components of LINC are 
 SUN-domain NETs embedded in the inner nuclear membrane 
that bind lamins in the nucleoplasm and Klarsicht/ANC-1/
Syne homology (KASH)-domain NETs in the nuclear enve-
lope lumen that in turn connect to cytoplasmic filaments from 
the outer nuclear membrane. The 120-residue SUN domain 
defines a family with at least five members in mammals, all 
of which have been found in the inner nuclear membrane, 
though all but SUN1 and SUN2 are tissue-specific.59 The 
combination of a KASH domain that binds SUN domains 
and spectrin repeats defines the nesprin family.8,60,61 In mam-
malian cells, there are at least four SYNE genes that give rise 
to multiple nesprin isoforms through alternative splicing and 
transcription initiation.62 Nesprin-1 and -2 interact directly 
with the actin cytoskeleton.63–65 Nesprin-3 binds plectin 
through which it is suggested to connect to cytoplasmic 
IFs,66 though plectin interfaces with all three cytoplasmic 
filament systems. Nesprin-4 and the related KASH5 (that 
lacks spectrin repeats), respectively, bind kinesin and 
dynein, plus- and minus-end-directed microtubule-dependent 
motors.67,68 These interactions may support a connection of 
the nucleoskeleton to microtubules, though the tissue-specific 
expression of nesprin-4 in hair cells of the inner ear and of 
KASH5 in germ cells means that either microtubule connec-
tions are tissue-specific or other NETs mediate connections 
to the microtubules. An interesting study suggested that some 
nesprins bind each other to generate a protein scaffold on 
the outer nuclear membrane,69 thus providing a more stable 
surface for connections to cytoplasmic filaments.
In the context of filament network connections or cellular 
“tensegrity,” LINC acts as a local force projection site for 
the nucleus. Disruption of LINC should therefore not only 
affect the connection itself but would have an effect on the 
architecture and function of both the nucleus and cytoplasm. 
This has been investigated by several laboratories, each using 
different specially designed tools to deform the nucleus/
cytoplasm and measure the effects of this strain on the 
 system. The Wirtz laboratory found that disruption of LINC 
by overexpression of dominant-negative SUN or KASH 
domains leads to abnormal actin and vimentin organization 
and causes the nucleus to deform less under applied stress.70 
More tellingly, disruption of LINC profoundly reduces 3D 
cell migration in a soft collagen matrix.71 As cell migration 
is principally directed by lammelipodia at the leading edge of 
the cell, the ability of this process to be affected by disrupt-
ing the connection of the actin cytoskeleton to the nucleus 
at the far end of the entire actin network strongly supports 
mechanical aspects predicted by tensegrity. As expected for 
an interconnected network, nucleoskeletal disruption also 
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affects these properties, with the Lammerding laboratory 
finding that Lmna-/- mouse cells72 have more fragile and 
easily deformable nuclei and exhibit migration defects in 
2D assays compared to wild-type.73 Although cytoskeleton 
architecture was visually intact, an overall increase in stiff-
ness was measured by microrheology.73 The Broers and 
Ramaekers laboratories obtained similar results using a dif-
ferent approach, with Lmna-/- nuclei exhibiting an isotropic 
deformation upon indentation, though the rest of the cell had 
an anisotropic deformation.74 Thus, nucleoskeletal weakening 
by disruption of lamin A or nucleo-cytoplasmic connectivity 
makes the nucleus more deformable, but at the same time it 
impairs force transmission so that it is irresponsive to external 
mechanical stimuli.
For all the distinct characteristics that different lamin 
subtypes can confer to the polymers they form, much 
more variation can be contributed by the many tissue-
specific nucleoskeletal components. For example, the 
 LINC-component splice variant nesprin-2ε
1
 is specific to 
early embryonic cells while short nesprins 1α
2
 and 2α
1
 are 
restricted to heart and muscle tissues75 and several nesprin and 
SUN genes are tissue-specifically expressed.67,68,76 Several 
widely expressed and tissue-specific NETs may influence 
LINC or support separate interactions with cytoplasmic 
 filaments. NET5 (Samp1) interacts with the LINC component 
SUN177 and also contributes to more specialized TAN lines 
that serve as tracks for nuclear migration within the cell.78 
NET5 also binds lamin A and is observed at spindle poles 
during mitosis, while its knockdown affects centrosome 
positioning,79 suggesting an additional role mediating nucleo-
skeletal associations with microtubules. Interestingly, two 
NETs found in proteomics of muscle nuclear envelopes, 
Tmem214 and WFS1, similarly accumulate at spindle poles 
during mitosis, and Tmem214 along with a third muscle 
NET KLHL31 partially tracks with microtubules on the 
nuclear surface in interphase.12 Future work will likely reveal 
additional NETs that participate in specific nucleoskeletal 
connections with cytoplasmic filament systems.
Chromatin, a component  
of the nucleoskeleton?
Thus far, we have focused on the side of the lamin poly-
mer facing outward, but the nucleoplasmic face is not less 
active. Many labs have shown that lamins can bind specific 
types of DNA/chromatin including beta-heterochromatin in 
Drosophila, MARs, SARs, telomeres, centromeres, and core 
histones – specifically H2A and H2B.76 There appear to be 
both weak binding sites in the lamin coiled-coil domain80,81 
and high-affinity binding sites in the C-terminal domain.82,83 
Furthermore, lamins can bind a variety of transcriptional 
regulators including pRb, cFos, and Mok2.84 This is thought 
to sequester these factors away from their target genes that 
tend to be more internal in the nucleus, but if a gene is 
proximal to lamins, it could have an activating effect. Indeed, 
ChIP-sequencing of lamin A-associated chromatin revealed a 
mixture of active and repressed genes.85 However, this study 
could not distinguish between contributions from a lesser 
nucleoplasmic pool of lamins and the membrane-associated 
polymer. It is also unclear whether lamin contributions to 
spatial genome organization are directed by lamin–chromatin 
interactions, lamin–transcriptional regulator interactions, or 
lamin–NET interactions. Nonetheless, defective lamin B1 
results in release of chromosome 18 from the periphery,86 
and lamin A mutations associated with human disease 
(see below) cause changes in the positioning of certain 
chromosomes.87
Several NETs also interact directly with chromatin and/or 
transcriptional regulators. Lamin B receptor (LBR) binds H3/
H4 histones,88 favoring histone H3 with the silencing lysine 9 
tri-methylation mark,89 and also binds heterochromatin pro-
tein 1 (HP1).90 LAP2β binds barrier-to-autointegration factor 
(BAF),76 the transcriptional repressor germ cell-less (gcl),91 
and the chromatin-remodeling factor histone deacetylase 3.92 
Interestingly, emerin was subsequently shown to bind these 
same factors,93,94 but it also has additional specific interactions 
with the transcriptional repressor Btf95 and the transcription 
factor Lmo7.96 These NETs are all widely expressed, and 
so could only contribute tissue-specific genome regulatory 
functions through the medium of tissue-specific chromatin 
or chromatin/DNA regulating binding partners. In contrast, 
there are several highly tissue-specific NETs that direct 
tissue-specific patterns of genome organization. TAPBPL, 
STT3A, NET5, NET29, NET39, NET45, and NET47 all 
can direct particular subsets of chromosomes to the nuclear 
periphery.11,97
All of the genome-linked NETs tested thus far also bind 
lamins, and so are also parts of the nucleoskeleton. This 
should enable lamins and NETs to work in concert to achieve 
their functions in genome organization and regulation. 
Indeed, LBR and lamin A together achieve a general pattern 
of heterochromatin distribution at the nuclear periphery that 
is disrupted when these components are removed.98 More 
specific gene positioning can be achieved with a different 
nexus of LAP2β with lamin B1 and histone deacetylase 3 
that directs the IgH and Cyp3a loci to the nuclear periphery 
in lymphocytes.99 Lamin and interacting NET effects on the 
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genome also include RNA splicing,100 DNA replication,101,102 
and DNA damage repair responses.103
All of the above examples focus on the role of the genome 
as the repository of the genetic material and the regulation of 
that material. Chromosomes, however, can also be viewed as 
the largest individual molecules of the cell. In fact, a chro-
mosome makes a megadalton molecule like titin, the largest 
protein in the cell and a contributor to the organization of 
the actin cytoskeleton, seem tiny in comparison. Such large 
molecules could easily contribute to the tensegrity network 
of the nucleoskeleton and through this to that of the whole 
cytoskeleton. While this is a rather novel way to view the 
genome, it is consistent with observations that during mitosis 
the attachment of a large chromosome to individual microtu-
bules actually stabilize the microtubules and eventually the 
whole microtubule spindle.104 We propose that in interphase 
the decondensed chromosomes could act as a buffer for 
forces generated by cytoskeletal mechanics similar to how a 
cushion absorbs force when sat on. This idea also may shed 
light on the logic of evolution in making the protein nucleo-
skeleton almost exclusively from IFs and associated NETs. 
The extreme elasticity and tensile strength of the IF lamin 
polymer enables it to stretch under considerable force without 
breaking. As it sits between the powerful forces of the cyto-
plasmic filaments in their tensegrity network on one side and 
the powerful forces of the chromosomes on the other side, 
the lamin polymer endures probably the strongest pushing 
and pulling forces in the cell. That most chromatin binding 
NETs also bind to lamins and lamins also bind chromatin 
supports a multiplicity of docking sites for the genome, while 
having many different, mostly multispanning transmembrane 
proteins as part of this nexus provides for strong interactions 
with the membrane.16 Having multiple NETs engage in mul-
tiple connections to multiple cytoplasmic filament networks 
further distributes the load-bearing in the greater genome–
nucleoskeleton–cytoplasmic filament tensegrity system. At 
this stage, however, this is just speculation.
Signaling through the 
nucleoskeleton
The connectivity of these various networks could support 
mechanotransduction of signals directly from the plasma 
membrane/extracellular matrix to the nucleus. Direct mechan-
ical signaling should transmit a force applied at one end of 
the network to its other end in a matter of microseconds in 
contrast to the several seconds it would take for protein inter-
actions and trafficking through the cell and nuclear pore com-
plexes to get a normal protein–chemical  signaling  pathway 
from the plasma membrane to the  nucleus.105  Consistent 
with the idea that mechanotransduction does indeed occur 
through cytoplasmic filament–nucleoskeleton connections, 
two different types of high-tension and  low-tension actin 
fibers have been observed at the nuclear membrane. The 
high-tension fibers presumably contribute to tensegrity for 
the overall cell shape and stability. The low-tension fibers are 
focused at the actin cap on the nuclear surface and connect to 
the nucleoskeleton via the LINC complex.106 If high-tension 
fibers were involved in mechanotransduction, it is likely that 
the cell would become overstimulated due to the considerable 
dynamics of the cytoskeleton; therefore, it makes sense for 
the cell to have an independent low-tension network for the 
separate function of signal transduction.
An underlying contribution of mechanotransduction in 
nuclear membrane signaling is further indicated by impaired 
nuclear localization and signaling function of the mechano-
sensitive transcription factor megakaryoblastic leukemia 1 
(MKL1) in cells from Lmna-/- mice.107 This impaired function 
appears to be a consequence of disrupted actin dynamics due 
to emerin mislocalization with its binding partner, lamin A, 
gone because exogenous overexpression of emerin rescued 
both the actin dynamics and the MKL1 function.107 Other 
protein signaling cascades that depend on nucleoskeletal 
NETs include emerin impacting on β-catenin signaling108 
and MAN1 on Smad and TGF-β signaling.109,110  Additionally, 
the mitogen-activated protein kinase (MAPK) and extracel-
lular signal-regulated kinase (ERK) pathways are affected, 
respectively, by emerin111 and lamin depletion,112 though 
there is no evidence at this point to indicate any links to 
mechanotransduction or tensegrity.
Mutations in nucleoskeletal  
proteins cause human disease
Mutations in lamins and several NETs of the nucleoskeleton 
cause a wide range of human diseases that include several 
muscular dystrophies, cardiomyopathies, dermopathy, neu-
ropathies, bone disorders, lipodystrophies, and premature 
aging syndromes (Table 1).113 There are three core mecha-
nisms proposed to explain how a mutation in a nuclear enve-
lope protein could yield pathology. The first is that the cell 
cycle and/or stem cell maintenance is affected, resulting in a 
failure to regenerate damaged tissues from satellite cells. The 
second is that regulation of gene expression is altered, thus 
interfering with normal tissue function and metabolism. The 
third is that a weakening of the nucleoskeletal connections 
to the cytoplasmic filament systems results in increased sus-
ceptibility to mechanical stress – especially in cells suffering 
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an intense mechanical strain such as muscle.114,115 It is likely 
that all three mechanisms contribute to disease pathology: for 
example, in muscle, increased susceptibility to mechanical 
stress could result in altered chromatin organization, which 
causes altered gene expression that finally results in satellite 
cells undergoing premature differentiation, thus depleting the 
pool of cells that can regenerate damaged tissue.
The tissue specificity of nuclear-envelope-linked diseases 
is curious, as different mutations in the widely expressed 
lamin A protein can cause distinct diseases such as muscular 
dystrophies,116–118 neuropathies,119 dermopathies,120 and lip-
odystrophies.121,122 Even more strikingly, each of the lamin 
A-linked muscular dystrophies affects a separate or partly 
overlapping set of specific muscle groups – shoulder, upper 
arm, calf muscles, and heart in Emery–Dreifuss muscular 
dystrophy (EDMD),123 proximal muscles (shoulder girdle and 
pelvic girdle) in limb–girdle muscular dystrophy (LGMD),124 
and heart in dilated cardiomyopathy (DCM).125 Some of this 
tissue specificity of pathology could be due to the postulated 
tissue-specific partner proteins,126 but particularly in the 
muscular dystrophies the mechanical instability may well 
be the driving force.
EDMD has thus far been linked not only to lamin A 
but also to the NETs emerin, nesprin-1, nesprin-2, SUN1, 
SUN2, and Tmem43 (Luma).116,127–130 Four of these NETs are 
components of the LINC complex8 while emerin connects 
to both lamins131 and the postulated tensegrity chromosomal 
component93–96 and Tmem43 binds lamins, SUN2, and 
 emerin.128 Some degree of tissue specificity can be observed 
in the proteins in this system, as EDMD disease-causing 
mutations have been found in the more muscle-specific 
nesprin isoforms 1α and 2β and myotubes generated in vitro 
from biopsy of patients with these mutations had disrupted 
the sarcomere structure.130 While all these connections sup-
port the mechanical instability hypothesis, it is notable that, 
though some lamin A mutations resulted in filament assembly 
Table 1 Diseases linked to nucleoskeletal proteins
Gene name Disease OMIM Reference
LMNA emery–Dreifuss muscular dystrophy 2, AD #181350 116
emery–Dreifuss muscular dystrophy 3, AR #181350 170
Muscular dystrophy, congenital #613205 118
Muscular dystrophy, limb–girdle, type 1B #159001 117
Cardiomyopathy, dilated, 1A #115200 171
Lipodystrophy, familial partial, 2 #176670 121,122
Charcot–Marie–Tooth disease, type 2B1 #605588 119
Heart–hand syndrome, Slovenian type #150330 172
Malouf syndrome #212112 173
Hutchinson–Gilford progeria syndrome #176670 147,148
Mandibuloacral dysplasia #248370 174
Restrictive dermopathy, lethal #275210 120
LMNB1 Leukodystrophy, adult-onset #169500 157
LMNB2 Lipodystrophy, partial, acquired, susceptibility to #608709 158
LBR Greenberg skeletal dysplasia #215140 175
Pelger–Huet anomaly #169400 142
EMD Emery–Dreifuss muscular dystrophy 1, X-linked #310300 129
SYNE1 Spinocerebellar ataxia 8 #610743 176
emery–Dreifuss muscular dystrophy 4 #612998 130
SYNE2 emery–Dreifuss muscular dystrophy 5 #612999 130
SYNE4 Deafness 76 #615540 144
SUN1 emery–Dreifuss muscular dystrophy 127
SUN2 emery–Dreifuss muscular dystrophy 127
LEMD3 (MAN1) Buschke–Ollendorff syndrome #166700 177
Melorheostosis with osteopoikilosis #155950 178
Osteopoikilosis #166700 177
TMEM43 Arrhythmogenic right ventricular dysplasia 5 #604400 179
emery–Dreifuss muscular dystrophy 7 #614302 128
TOR1AIP1 (LAP1) Muscular dystrophy with rigid spine, contractures  
of hand joints and cardiomyopathy
180
TMPO (LAP2) Cardiomyopathy, dilated, 1T #613740 181
DTNA Left ventricular noncompaction 1 #604169 182
Abbreviations: OMiM, Online Mendelian inheritance in Man; AD, autosomal dominant inheritance; AR, autosomal recessive inheritance.
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defects in vitro, others did not,132 indicating that this is not 
a general characteristic of the disease. At the same time, 
a potential chromatin disruption role is supported by elec-
tron microscopy observations of disrupted peripheral dense 
chromatin in EDMD patient biopsy sections. Furthermore, 
defects in gene expression were observed in biopsy from 
other EDMD patients, particularly of the muscle myoD gene 
and the cell cycle regulator pRb that plays a role in both satel-
lite cell maintenance and the cell cycle withdrawal necessary 
for myotube differentiation.133 More telling for the myoD 
defects, lamin A was required for myoD repositioning away 
from the nuclear envelope associated with its activation in 
Caenorhabditis elegans, and this repositioning failed when 
lamin A carrying specific EDMD lamin point mutations was 
expressed.134
The finding that several interacting components of the 
nucleoskeleton can each, when mutated, cause the same 
EDMD disease pathology supports the idea of tensegrity 
playing a role in the nuclear envelope system. Even more 
compelling to the idea of tensegrity is the finding that the 
combination of multiple nucleoskeletal protein mutations 
leads to more severe disease than the individual component 
mutations (Figure 3). For example, emerin mutations, which 
alone cause mild clinical presentation with the patients fully 
ambulatory, when combined with SUN1 mutations yield 
wheelchair dependency.127 Also lamin A mutations, when 
combined with emerin, SUN1, or SUN2 mutations, result in 
a more severe presentation.18,127,135,136 The tensegrity model is 
even more strongly supported by a similar increase in disease 
severity when a nucleoskeleton mutation (emerin) is com-
bined with a mutation in cytoplasmic filaments (desmin).137 
Although such modifier mutations are yet to be found in 
LGMD, it is compelling in light of this model that, apart 
from mutations in lamin A, this disease can also be caused 
by mutations in the cytoplasmic filament system proteins 
plectin,138 desmin,139 and titin140 as well as the connected 
exoskeleton protein integrin alpha-7.141 Thus, weakening 
of any part of the nucleoskeletal–cytoskeletal–exoskeletal 
system can generate a similar pathology consistent with 
mechanical instability.
Another nucleoskeletal NET evidently linked to mechani-
cal instability is the LBR. In contrast to most of the NETs 
above that are involved in LINC connections to cytoplasmic 
filaments, LBR functions in connecting the nucleoskeleton to 
chromatin. LBR mutations cause a blood granulocyte disorder 
characterized by abnormal nuclear morphology and chromatin 
organization named the Pelger–Huet anomaly.142 Granulocyte 
nuclei normally undergo extensive cytoskeletal reorganization 
to become highly lobulated when they further differentiate to 
neutrophils; however, the nuclei remain spherical in Pelger–
Huet anomaly.142 Interestingly,  granulocyte nuclei have high 
levels of lamin B2, the “weakest” lamin, compared to other 
subtypes.45,143 Thus, LBR connections to chromatin likely 
provide a counter force to support lobulation in a weak lamin 
background while disruption of this tensegrity element by loss 
of LBR results in failure to lobulate.
Two other diseases are likely linked to nucleoskeletal 
mechanotransduction. In one, a mutation in tissue-specific 
nesprin-4 affects positioning of the nucleus specifically in 
the mechanosensory hair cells leading to autosomal reces-
sive deafness.144 The other is familial cardiomyopathy with 
conduction defect, where mice expressing a specific lamin 
A cardiomyopathy mutation (N195K/N195K) exhibit the 
same defects in the MKL1 mechanosensitive transcrip-
tion factor as the Lmna-/- mice.107 Mouse models of lamin 
A-linked cardiomyopathy also affect the MAPK and ERK 
kinase pathways.145,146
The progeroid syndromes appear to be quite different, 
exhibiting defects in the processing and assembly of lamins. 
The normal transient lamin A farnesylation is disrupted in 
slightly different ways to yield the Hutchinson–Gilford pro-
geria syndrome (HGPS),147,148 mandibuloacral dysplasia,149 
Figure 3 Combined mutations at different points of nucleoskeletal–cytoplasmic filament contacts could yield more severe disease pathologies.
Notes: (A) A normal healthy cell has cytoskeletal connections to the nucleus and to the plasma membrane. (B) Disruption of just one of these connections (red marks) 
could lead to significant structural damage to the cell. (C) Disruption of both connections (red marks) would be far more consequential.
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and restrictive dermopathy (RD),120 but all these disorders 
are characterized by the failure to remove the farnesyl 
group. HGPS is most commonly caused by a heterozygous 
mutation resulting in a 50-amino acid deletion in lamin A, 
which includes the C-terminal cleavage site for the protease 
ZMPSTE24 needed to remove the farnesyl group.144,148 
The resulting mutated protein is commonly referred to as 
 progerin. In contrast, RD is caused by mutations result-
ing in a loss of ZMPSTE24 that cause an accumulation of 
farnesylated, unprocessed full-length prelamin A. Thus, both 
remain farnesylated, but progerin has an additional deletion 
and, being heterozygous 50% of the lamin A, is wild-type. 
These differences account for an enormous distinction in 
 pathologies. HGPS patients appear healthy at birth but 
develop a progeroid phenotype including extreme short 
stature, low body weight, early hair loss, lipodystrophy, scle-
roderma, decreased joint mobility, and osteolysis within the 
course of 1–2 years. In most cases, cardiovascular problems 
cause death in the second decade.150 RD invariably yields 
neonatal death or death in early infancy. Clinical features 
include tightly adherent thin skin, generalized joint contrac-
tures, dysplasia of clavicles, increased subcutaneous fat, and 
respiratory insufficiency.56 Mandibuloacral dysplasia, caused 
by partial loss of ZMPSTE24 function due to combinations of 
missense and nonsense mutations, is characterized by postna-
tal growth retardation, craniofacial anomalies, skin changes 
such as atrophy and speckled hyperpigmentation, as well as 
accumulation of fat in the neck and moderate lipodystrophy 
of the limbs with a median age of death of 30 years.56
As the permanently farnesylated B-type lamins formed a 
different type of network from lamin A when exogenously 
expressed in Xenopus, it is likely that the maintained asso-
ciation with the membrane alters the polymer structure. 
However, the principal findings to date favor the genome 
face of lamins in the pathology of HGPS, with chromatin 
disorganization, DNA damage, and genome instability as 
the primary culprits.151–153 This is further supported by the 
involvement of the NET-interacting chromatin protein BAF 
in another progeroid disorder, the Nestor–Guillermo progeria 
syndrome (OMIM #614008).154 But progeria is also linked 
to LMNA mutations not associated with a failure of lipid 
 processing. Patients with these mutations often have pheno-
types overlapping between different progeroid syndromes or 
other laminopathies.155,156
Finally, it is worth noting that lamin B1 has been linked 
to leukodystrophy157 and lamin B2 to partial lipodystrophy,158 
though little is known about the pathogenic mechanism, 
and lamins have also been linked to cancer. In fact, loss of 
lamin A was one of the first historical biomarkers associated 
with increased metastasis;159 however, the focus on this was 
dropped because such trends differed in different tumor 
types.160 Nonetheless, recent work has indicated that nucleo-
skeleton involvement in basic cellular processes such as 
maintenance of nuclear shape and size, centrosomal position-
ing, cell migration and signal transduction, and DNA damage 
repair all likely contribute to the formation of a wide range 
of cancers.161,162
Therapeutic target identification 
and screening approaches
Thus far, there are no treatments to “cure” any of the 
nucleoskeleton-linked muscular dystrophies. Nonetheless, 
some approaches are currently being investigated.163 One 
such approach is exon skipping, because the exon–intron 
structure of lamin A enables the removal of some entire exons 
within the coiled-coil domain without disrupting the heptad 
structure of the coiled coil.164
Another promising approach is the targeting of signaling 
pathways affected by the nucleoskeleton. Inhibitors of ERK 
and MAPK have yielded positive effects on preventing car-
diomyopathy in mouse models expressing lamin A mutations 
causative of the disease;145,165 also MAPK inhibition in an 
EDMD mouse model improved the muscular phenotype.166
In the case of HGPS, due to the accumulation of the 
farnesylated prelamin A, the farnesyl transferase was 
targeted. However, while this yielded considerable improve-
ments in the tissue culture aspects of nuclear morphology 
and chromosome organization,55 there were only minor 
benefits in aspects such as the overall body weight in the 
patients.167 Potential therapies for HGPS are now target-
ing its links to genome organization/stability, as chemical 
inhibition of NAT10, a lysine acetyletransferase, was also 
found to restore normal nuclear morphology in HGPS 
cultured cells.168
To the extent that tissue-specific NETs may contribute to 
particular nucleo/cytoskeletal structures, these also could be 
targeted. As lamin A and core LINC components are univer-
sally expressed, targeting these tissue-specific partners should 
have less damaging off-target effects. However, as these 
partners are only beginning to be identified, such therapies 
are not likely to be realized in the near future.
Wider considerations  
and future directions
The observation that multiple components that interact in 
the nucleoskeleton and cytoplasmic filament systems can 
Cell Health and Cytoskeleton 2015:7 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
65
Nucleoskeleton dynamics and functions in health and disease
all yield variants of the same disease is a powerful argument 
for the idea of a tensegrity-type network connectedness in 
the function of the nuclear envelope and nucleoskeleton. 
While the idea that the genome could itself be a component of 
the overall cellular tensegrity system may be viewed by some 
as radical, it nonetheless comports with much of the exist-
ing data on the nucleoskeleton. This idea of the mechanical 
connectedness of these systems has recently gained traction 
with recent findings that lamin A levels scale with tissue 
elasticity. Low lamin A levels better supported differentia-
tion of fat, while higher lamin levels improved differentiation 
of the much stiffer bone tissue.169 Matrix stiffness directly 
influenced lamin A levels, suggesting that its expression is 
increased to compensate/normalize the overall force applied 
on the nucleus in these tissues. Thus, the mechanics of the 
nucleo–cytoskeleton nexus are important for many aspects of 
nuclear function in both normal human health and disease.
Acknowledgments
Work in the Schirmer lab is supported by Wellcome Trust 
Senior Research Fellowship 095209 and Centre Grant 
092076. PLT is supported by an MRC Studentship. AM is 
supported by a Principal’s Scholarships from the University 
of Edinburgh.
Disclosure
The authors declare no conflicts of interest in this work.
References
 1. Lodish H, Berk A, Zipursky SL, Matsudaira P, Baltimore D, Darnell J. 
Molecular Cell Biology. 4th ed. New York: WH Freeman; 2000.
 2. Sperry AO. The dynamic cytoskeleton of the developing male germ 
cell. Biol Cell. 2012;104(5):297–305.
 3. Fisher DZ, Chaudhary N, Blobel G. cDNA sequencing of nuclear 
lamins A and C reveals primary and secondary structural homology to 
intermediate filament proteins. Proc Natl Acad Sci U S A. 1986;83(17): 
6450–6454.
 4. Krohne G, Debus E, Osborn M, Weber K, Franke WW. A monoclonal 
antibody against nuclear lamina proteins reveals cell type-specificity 
in Xenopus laevis. Exp Cell Res. 1984;150(1):47–59.
 5. Zackroff RV, Goldman AE, Jones JC, Steinert PM, Goldman RD. 
 Isolation and characterization of keratin-like proteins from cultured cells 
with fibroblastic morphology. J Cell Biol. 1984;98(4):1231–1237.
 6. Gerace L, Comeau C, Benson M. Organization and modulation of 
nuclear lamina structure. J Cell Sci Suppl. 1984;1:137–160.
 7. Aebi U, Cohn J, Buhle L, Gerace L. The nuclear lamina is a meshwork 
of intermediate-type filaments. Nature. 1986;323(6088):560–564.
 8. Crisp M, Liu Q, Roux K, et al. Coupling of the nucleus and cytoplasm: 
role of the LINC complex. J Cell Biol. 2006;172(1):41–53.
 9. Dreger M, Bengtsson L, Schoneberg T, Otto H, Hucho F. Nuclear enve-
lope proteomics: novel integral membrane proteins of the inner nuclear 
membrane. Proc Natl Acad Sci U S A. 2001;98(21):11943–11948.
 10. Schirmer EC, Florens L, Guan TL, Yates JR, Gerace L. Nuclear 
membrane proteins with potential disease links found by subtractive 
proteomics. Science. 2003;301(5638):1380–1382.
 11. Korfali N, Wilkie GS, Swanson SK, et al. The leukocyte nuclear enve-
lope proteome varies with cell activation and contains novel transmem-
brane proteins that affect genome architecture. Mol Cell Proteomics. 
2010;9(12):2571–2585.
 12. Wilkie GS, Korfali N, Swanson SK, et al. Several novel nuclear enve-
lope transmembrane proteins identified in skeletal muscle have cytoskel-
etal associations. Mol Cell Proteomics. 2011;10(1):M110.003129.
 13. Korfali N, Wilkie GS, Swanson SK, et al. The nuclear envelope pro-
teome differs notably between tissues. Nucleus. 2012;3(6):552–564.
 14. Dittmer TA, Sahni N, Kubben N, et al. Systematic identification of path-
ological lamin A interactors. Mol Biol Cell. 2014;25(9):1493–1510.
 15. Zastrow MS, Vlcek S, Wilson KL. Proteins that bind A-type lamins: 
integrating isolated clues. J Cell Sci. 2004;117(pt 7):979–987.
 16. Zuleger N, Robson MI, Schirmer EC. The nuclear envelope as a chro-
matin organizer. Nucleus. 2011;2(5):339–349.
 17. Capell BC, Collins FS. Human laminopathies: nuclei gone genetically 
awry. Nat Rev Genet. 2006;7(12):940–952.
 18. Meinke P, Nguyen TD, Wehnert MS. The LINC complex and human 
disease. Biochem Soc Trans. 2011;39:1693–1697.
 19. de Las Heras JI, Meinke P, Batrakou DG, et al. Tissue specificity in 
the nuclear envelope supports its functional complexity. Nucleus. 
2013;4(6):460–477.
 20. Wilkie GS, Schirmer EC. Guilt by association: the nuclear envelope 
proteome and disease. Mol Cell Proteomics. 2006;5(10):1865–1875.
 21. Fuchs E, Weber K. Intermediate filaments: structure, dynamics, func-
tion, and disease. Annu Rev Biochem. 1994;63:345–382.
 22. Strelkov SV, Herrmann H, Aebi U. Molecular architecture of intermedi-
ate filaments. Bioessays. 2003;25(3):243–251.
 23. Vikstrom KL, Lim SS, Goldman RD, Borisy GG. Steady-state dynamics 
of intermediate filament networks. J Cell Biol. 1992;118(1):121–129.
 24. Okabe S, Hirokawa N. Dynamics of the neuronal microtubules and 
intermediate filaments studied by laser fluorescence photobleach 
recovery method and caged fluorescence UV photoactivation method. 
Mol Biol Cell. 1992;3:A2–A2.
 25. Janmey PA, Euteneuer U, Traub P, Schliwa M. Viscoelastic properties 
of vimentin compared with other filamentous biopolymer networks. 
J Cell Biol. 1991;113(1):155–160.
 26. Shen X, Ranallo R, Choi E, Wu C. Involvement of actin-related pro-
teins in ATP-dependent chromatin remodeling. Mol Cell. 2003;12(1): 
147–155.
 27. Belin BJ, Mullins RD. What we talk about when we talk about nuclear 
actin. Nucleus. 2013;4(4):291–297.
 28. Wada A, Fukuda M, Mishima M, Nishida E. Nuclear export of actin: 
a novel mechanism regulating the subcellular localization of a major 
cytoskeletal protein. EMBO J. 1998;17(6):1635–1641.
 29. Gerace L, Burke B. Functional organization of the nuclear envelope. 
Annu Rev Cell Biol. 1988;4:335–374.
 30. Peter M, Kitten GT, Lehner CF, et al. Cloning and sequencing of 
cDNA clones encoding chicken lamins A and B1 and comparison of 
the primary structures of vertebrate A- and B-type lamins. J Mol Biol. 
1989;208(3):393–404.
 31. Weber K, Plessmann U, Ulrich W. Cytoplasmic intermediate filament 
proteins of invertebrates are closer to nuclear lamins than are vertebrate 
intermediate filament proteins; sequence characterization of two muscle 
proteins of a nematode. EMBO J. 1989;8(11):3221–3227.
 32. Loewinger L, McKeon F. Mutations in the nuclear lamin proteins 
resulting in their aberrant assembly in the cytoplasm. EMBO J. 
1988;7(8):2301–2309.
 33. Lazebnik YA, Takahashi A, Moir RD, et al. Studies of the lamin pro-
teinase reveal multiple parallel biochemical pathways during apoptotic 
execution. Proc Natl Acad Sci U S A. 1995;92(20):9042–9046.
 34. Holtz D, Tanaka RA, Hartwig J, McKeon F. The CaaX motif of lamin 
A functions in conjunction with the nuclear localization signal to target 
assembly to the nuclear envelope. Cell. 1989;59(6):969–977.
 35. Nigg EA, Kitten GT, Vorburger K. Targeting lamin proteins to the 
nuclear envelope: the role of CaaX box modifications. Biochem Soc 
Trans. 1992;20(2):500–504.
Cell Health and Cytoskeleton 2015:7submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
66
Meinke et al
 36. Mical TI, Monteiro MJ. The role of sequences unique to nuclear inter-
mediate filaments in the targeting and assembly of human lamin B: 
evidence for lack of interaction of lamin B with its putative receptor. 
J Cell Sci. 1998;111:3471–3485.
 37. Monteiro MJ, Hicks C, Gu L, Janicki S. Determinants for intracellular 
sorting of cytoplasmic and nuclear intermediate filaments. J Cell Biol. 
1994;127(5):1327–1343.
 38. Broers JL, de Leij L, Rot MK, et al. Expression of intermediate fila-
ment proteins in fetal and adult human lung tissues. Differentiation. 
1989;40(2):119–128.
 39. Jansen MP, Machiels BM, Hopman AH, et al. Comparison of A and 
B-type lamin expression in reactive lymph nodes and nodular sclerosing 
Hodgkin’s disease. Histopathology. 1997;31(4):304–312.
 40. Broers JL, Ramaekers FC. Dynamics of nuclear lamina assembly and 
disassembly. Symp Soc Exp Biol. 2004;56:177–192.
 41. Machiels BM, Zorenc AH, Endert JM, et al. An alternative splic-
ing product of the lamin A/C gene lacks exon 10. J Biol Chem. 
1996;271(16):9249–9253.
 42. Alsheimer M, Benavente R. Change of karyoskeleton during mam-
malian spermatogenesis: expression pattern of nuclear lamin C2 and 
its regulation. Exp Cell Res. 1996;228(2):181–188.
 43. Furukawa K, Hotta Y. cDNA cloning of a germ cell specific lamin 
B3 from mouse spermatocytes and analysis of its function by ectopic 
expression in somatic cells. EMBO J. 1993;12(1):97–106.
 44. Letai A, Fuchs E. The importance of intramolecular ion pairing in 
intermediate filaments. Proc Natl Acad Sci U S A. 1995;92(1):92–96.
 45. Schirmer EC, Gerace L. The stability of the nuclear lamina polymer 
changes with the composition of lamin subtypes according to their indi-
vidual binding strengths. J Biol Chem. 2004;279(41):42811–42817.
 46. Panorchan P, Wirtz D, Tseng Y. Structure-function relationship of 
biological gels revealed by multiple-particle tracking and differential 
interference contrast microscopy: the case of human lamin networks. 
Phys Rev E Stat Nonlin Soft Matter Phys. 2004;70(4 pt 1):27.
 47. Lammerding J. Mechanics of the nucleus. Compr Physiol. 2011;1(2): 
783–807.
 48. Isermann P, Lammerding J. Nuclear mechanics and mechanotransduc-
tion in health and disease. Curr Biol. 2013;23(24):009.
 49. von Moeller F, Barendziak T, Apte K, Goldberg MW, Stick R. 
 Molecular characterization of Xenopus lamin LIV reveals differences in 
the lamin composition of sperms in amphibians and mammals. Nucleus. 
2010;1(1):85–95.
 50. Shimi T, Pfleghaar K, Kojima S, et al. The A- and B-type nuclear 
lamin networks: microdomains involved in chromatin organization 
and transcription. Genes Dev. 2008;22(24):3409–3421.
 51. Delbarre E, Tramier M, Coppey-Moisan M, Gaillard C, Courvalin JC, 
Buendia B. The truncated prelamin A in Hutchinson-Gilford progeria 
syndrome alters segregation of A-type and B-type lamin homopolymers. 
Hum Mol Genet. 2006;15(7):1113–1122.
 52. Schirmer EC, Guan T, Gerace L. Involvement of the lamin rod domain 
in heterotypic lamin interactions important for nuclear organization. 
J Cell Biol. 2001;153(3):479–489.
 53. Lutz RJ, Trujillo MA, Denham KS, Wenger L, Sinensky M. 
 Nucleoplasmic localization of prelamin A: implications for prenylation-
dependent lamin A assembly into the nuclear lamina. Proc Natl Acad 
Sci U S A. 1992;89(7):3000–3004.
 54. Firmbach-Kraft I, Stick R. The role of CaaX-dependent modifications 
in membrane association of Xenopus nuclear lamin B3 during meio-
sis and the fate of B3 in transfected mitotic cells. J Cell Biol. 1993; 
123(6 pt 2):1661–1670.
 55. Young SG, Fong LG, Michaelis S. Prelamin A, Zmpste24, misshapen 
cell nuclei, and progeria – new evidence suggesting that protein farne-
sylation could be important for disease pathogenesis. J Lipid Res. 
2005;46(12):2531–2558.
 56. Navarro CL, Esteves-Vieira V, Courrier S, et al. New ZMPSTE24 
(FACE1) mutations in patients affected with restrictive dermopathy or 
related progeroid syndromes and mutation update. Eur J Hum Genet. 
2014;22(8):1002–1011.
 57. Maniotis AJ, Chen CS, Ingber DE. Demonstration of mechanical con-
nections between integrins, cytoskeletal filaments, and nucleoplasm 
that stabilize nuclear structure. Proc Natl Acad Sci U S A. 1997;94(3): 
849–854.
 58. Ingber DE. Tensegrity: the architectural basis of cellular 
 mechanotransduction. Annu Rev Physiol. 1997;59:575–599.
 59. Mejat A, Misteli T. LINC complexes in health and disease. Nucleus. 
2010;1(1):40–52.
 60. Padmakumar VC, Libotte T, Lu W, et al. The inner nuclear membrane 
protein Sun1 mediates the anchorage of Nesprin-2 to the nuclear 
 envelope. J Cell Sci. 2005;118(pt 15):3419–3430.
 61. Stewart-Hutchinson PJ, Hale CM, Wirtz D, Hodzic D. Structural 
requirements for the assembly of LINC complexes and their function in 
cellular mechanical stiffness. Exp Cell Res. 2008;314(8):1892–1905.
 62. Burke B, Roux KJ. Nuclei take a position: managing nuclear location. 
Dev Cell. 2009;17(5):587–597.
 63. Padmakumar VC, Abraham S, Braune S, et al. Enaptin, a giant actin-
binding protein, is an element of the nuclear membrane and the actin 
cytoskeleton. Exp Cell Res. 2004;295(2):330–339.
 64. Zhang Q, Ragnauth C, Greener MJ, Shanahan CM, Roberts RG. The 
nesprins are giant actin-binding proteins, orthologous to Drosophila mel-
anogaster muscle protein MSP-300. Genomics. 2002;80(5):473–481.
 65. Zhen YY, Libotte T, Munck M, Noegel AA, Korenbaum E. NUANCE, 
a giant protein connecting the nucleus and actin cytoskeleton. J Cell 
Sci. 2002;115(pt 15):3207–3222.
 66. Wilhelmsen K, Litjens SH, Kuikman I, et al. Nesprin-3, a novel outer 
nuclear membrane protein, associates with the cytoskeletal linker protein 
plectin. J Cell Biol. 2005;171(5):799–810.
 67. Roux KJ, Crisp ML, Liu Q, et al. Nesprin 4 is an outer nuclear membrane 
protein that can induce kinesin-mediated cell polarization. Proc Natl 
Acad Sci U S A. 2009;106(7):2194–2199.
 68. Morimoto A, Shibuya H, Zhu X, et al. A conserved KASH domain 
protein associates with telomeres, SUN1, and dynactin during mam-
malian meiosis. J Cell Biol. 2012;198(2):165–172.
 69. Lu W, Schneider M, Neumann S, et al. Nesprin interchain associations 
control nuclear size. Cell Mol Life Sci. 2012;69(20):3493–3509.
 70. Lombardi ML, Zwerger M, Lammerding J. Biophysical assays to probe 
the mechanical properties of the interphase cell nucleus: substrate strain 
application and microneedle manipulation. J Vis Exp. 2011;(55):ii:3087.
 71. Khatau SB, Bloom RJ, Bajpai S, et al. The distinct roles of the nucleus 
and nucleus-cytoskeleton connections in three-dimensional cell 
 migration. Sci Rep. 2012;2(488):3.
 72. Sullivan T, Escalante-Alcalde D, Bhatt H, et al. Loss of A-type lamin 
expression compromises nuclear envelope integrity leading to muscular 
dystrophy. J Cell Biol. 1999;147(5):913–920.
 73. Lammerding J, Schulze PC, Takahashi T, et al. Lamin A/C deficiency 
causes defective nuclear mechanics and mechanotransduction. J Clin 
Invest. 2004;113(3):370–378.
 74. Broers JL, Peeters EA, Kuijpers HJ, et al. Decreased mechanical 
stiffness in LMNA-/- cells is caused by defective nucleo-cytoskeletal 
integrity: implications for the development of laminopathies. Hum Mol 
Genet. 2004;13(21):2567–2580.
 75. Duong NT, Morris GE, Lam le T, et al. Nesprins: tissue-specific 
expression of epsilon and other short isoforms. PLoS One. 2014;9(4): 
e94380.
 76. Mattout-Drubezki A, Gruenbaum Y. Dynamic interactions of nuclear 
lamina proteins with chromatin and transcriptional machinery. Cell Mol 
Life Sci. 2003;60(10):2053–2063.
 77. Gudise S, Figueroa RA, Lindberg R, Larsson V, Hallberg E. Samp1 
is functionally associated with the LINC complex and A-type lamina 
networks. J Cell Sci. 2011;124(pt 12):2077–2085.
 78. Borrego-Pinto J, Jegou T, Osorio DS, et al. Samp1 is a component 
of TAN lines and is required for nuclear movement. J Cell Sci. 
2012;125(pt 5):1099–1105.
 79. Buch C, Lindberg R, Figueroa R, Gudise S, Onischenko E, Hallberg E. 
An integral protein of the inner nuclear membrane localizes to the mitotic 
spindle in mammalian cells. J Cell Sci. 2009;122(pt 12):2100–2107.
Cell Health and Cytoskeleton 2015:7 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
67
Nucleoskeleton dynamics and functions in health and disease
 80. Shoeman RL, Traub P. The in vitro DNA-binding properties of puri-
fied nuclear lamin proteins and vimentin. J Biol Chem. 1990;265(16): 
9055–9061.
 81. Glass JR, Gerace L. Lamins A and C bind and assemble at the surface 
of mitotic chromosomes. J Cell Biol. 1990;111(3):1047–1057.
 82. Taniura H, Glass C, Gerace L. A chromatin binding site in the tail 
domain of nuclear lamins that interacts with core histones. J Cell Biol. 
1995;131(1):33–44.
 83. Goldberg M, Harel A, Brandeis M, et al. The tail domain of lamin Dm0 
binds histones H2A and H2B. Proc Natl Acad Sci U S A. 1999;96(6): 
2852–2857.
 84. Dechat T, Adam SA, Taimen P, Shimi T, Goldman RD. Nuclear lamins. 
Cold Spring Harb Perspect Biol. 2010;2(11):8.
 85. Lund E, Oldenburg AR, Delbarre E, et al. Lamin A/C-promoter inter-
actions specify chromatin state-dependent transcription outcomes. 
Genome Res. 2013;23(10):1580–1589.
 86. Malhas A, Lee CF, Sanders R, Saunders NJ, Vaux DJ. Defects in lamin B1 
expression or processing affect interphase chromosome position and 
gene expression. J Cell Biol. 2007;176(5):593–603.
 87. Puckelwartz MJ, Depreux FF, McNally EM. Gene expression, 
chromosome position and lamin A/C mutations. Nucleus. 2011;2(3): 
162–167.
 88. Polioudaki H, Kourmouli N, Drosou V, et al. Histones H3/H4 form 
a tight complex with the inner nuclear membrane protein LBR and 
heterochromatin protein 1. EMBO Rep. 2001;2(10):920–925.
 89. Makatsori D, Kourmouli N, Polioudaki H, et al. The inner nuclear 
membrane protein lamin B receptor forms distinct microdomains and 
links epigenetically marked chromatin to the nuclear envelope. J Biol 
Chem. 2004;279(24):25567–25573.
 90. Ye Q, Worman HJ. Interaction between an integral protein of the nuclear 
envelope inner membrane and human chromodomain proteins homolo-
gous to Drosophila HP1. J Biol Chem. 1996;271(25):14653–14656.
 91. Nili E, Cojocaru GS, Kalma Y, et al. Nuclear membrane protein LAP2beta 
mediates transcriptional repression alone and together with its binding 
partner GCL (germ-cell-less). J Cell Sci. 2001;114(pt 18):3297–3307.
 92. Somech R, Shaklai S, Geller O, et al. The nuclear-envelope protein 
and transcriptional repressor LAP2beta interacts with HDAC3 at the 
nuclear periphery, and induces histone H4 deacetylation. J Cell Sci. 
2005;118(pt 17):4017–4025.
 93. Demmerle J, Koch AJ, Holaska JM. The nuclear envelope protein 
emerin binds directly to histone deacetylase 3 (HDAC3) and activates 
HDAC3 activity. J Biol Chem. 2012;287(26):22080–22088.
 94. Lee KK, Haraguchi T, Lee RS, Koujin T, Hiraoka Y, Wilson KL. 
 Distinct functional domains in emerin bind lamin A and DNA-bridging 
protein BAF. J Cell Sci. 2001;114(pt 24):4567–4573.
 95. Haraguchi T, Holaska JM, Yamane M, et al. Emerin binding to Btf, 
a death-promoting transcriptional repressor, is disrupted by a mis-
sense mutation that causes Emery-Dreifuss muscular dystrophy. 
Eur J Biochem. 2004;271(5):1035–1045.
 96. Holaska JM, Rais-Bahrami S, Wilson KL. Lmo7 is an emerin-binding 
protein that regulates the transcription of emerin and many other 
muscle-relevant genes. Hum Mol Genet. 2006;15(23):3459–3472.
 97. Zuleger N, Boyle S, Kelly DA, et al. Specific nuclear envelope trans-
membrane proteins can promote the location of chromosomes to and 
from the nuclear periphery. Genome Biol. 2013;14(2):2013–2014.
 98. Solovei I, Wang AS, Thanisch K, et al. LBR and lamin A/C sequen-
tially tether peripheral heterochromatin and inversely regulate 
 differentiation. Cell. 2013;152(3):584–598.
 99. Zullo JM, Demarco IA, Piqué-Regi R, et al. DNA sequence-dependent 
compartmentalization and silencing of chromatin at the nuclear lamina. 
Cell. 2012;149(7):1474–1487.
 100. Kumaran RI, Muralikrishna B, Parnaik VK. Lamin A/C speckles 
mediate spatial organization of splicing factor compartments and RNA 
polymerase II transcription. J Cell Biol. 2002;159(5):783–793.
 101. Moir RD, Spann TP, Herrmann H, Goldman RD. Disruption of nuclear 
lamin organization blocks the elongation phase of DNA replication. 
J Cell Biol. 2000;149(6):1179–1192.
 102. Singh M, Hunt CR, Pandita RK, et al. Lamin A/C depletion enhances 
DNA damage-induced stalled replication fork arrest. Mol Cell Biol. 
2013;33(6):1210–1222.
 103. Lei K, Zhu X, Xu R, et al. Inner nuclear envelope proteins SUN1 and 
SUN2 play a prominent role in the DNA damage response. Curr Biol. 
2012;22(17):1609–1615.
 104. Alberts BJA, Lewis J, et al. Molecular Biology of the Cell. 4th ed. 
New York: Garland Science; 2002.
 105. Wang N, Tytell JD, Ingber DE. Mechanotransduction at a distance: 
mechanically coupling the extracellular matrix with the nucleus. Nat 
Rev Mol Cell Biol. 2009;10(1):75–82.
 106. Chambliss AB, Khatau SB, Erdenberger N, et al. The LINC-anchored 
actin cap connects the extracellular milieu to the nucleus for ultrafast 
mechanotransduction. Sci Rep. 2013;3(1087):18.
 107. Ho CY, Jaalouk DE, Vartiainen MK, Lammerding J. Lamin A/C and 
emerin regulate MKL1-SRF activity by modulating actin dynamics. 
Nature. 2013;497(7450):507–511.
 108. Markiewicz E, Tilgner K, Barker N, et al. The inner nuclear mem-
brane protein emerin regulates beta-catenin activity by restricting its 
accumulation in the nucleus. EMBO J. 2006;25(14):3275–3285.
 109. Pan D, Estévez-Salmerón LD, Stroschein SL, et al. The integral inner 
nuclear membrane protein MAN1 physically interacts with the R-Smad 
proteins to repress signaling by the transforming growth factor-{beta} 
superfamily of cytokines. J Biol Chem. 2005;280(16):15992–16001.
 110. Osada S, Ohmori SY, Taira M. XMAN1, an inner nuclear membrane 
protein, antagonizes BMP signaling by interacting with Smad1 in 
Xenopus embryos. Development. 2003;130(9):1783–1794.
 111. Muchir A, Pavlidis P, Bonne G, Hayashi YK, Worman HJ. Activation 
of MAPK in hearts of EMD null mice: similarities between mouse 
models of X-linked and autosomal dominant Emery Dreifuss muscular 
dystrophy. Hum Mol Genet. 2007;16(15):1884–1895.
 112. Muchir A, Wu W, Worman HJ. Reduced expression of A-type lamins 
and emerin activates extracellular signal-regulated kinase in cultured 
cells. Biochim Biophys Acta. 2009;1:75–81.
 113. Worman HJ. Nuclear lamins and laminopathies. J Pathol. 2012;226(2): 
316–325.
 114. Hutchison CJ, Alvarez-Reyes M, Vaughan OA. Lamins in disease: 
why do ubiquitously expressed nuclear envelope proteins give rise to 
tissue-specific disease phenotypes? J Cell Sci. 2001;114(pt 1):9–19.
 115. Hutchison CJ, Worman HJ. A-type lamins: guardians of the soma? 
Nat Cell Biol. 2004;6(11):1062–1067.
 116. Bonne G, Di Barletta MR, Varnous S, et al. Mutations in the gene 
encoding lamin A/C cause autosomal dominant Emery-Dreifuss 
muscular dystrophy. Nat Genet. 1999;21(3):285–288.
 117. Muchir A, Bonne G, van der Kooi AJ, et al. Identification of mutations 
in the gene encoding lamins A/C in autosomal dominant limb girdle 
muscular dystrophy with atrioventricular conduction disturbances 
(LGMD1B). Hum Mol Genet. 2000;9(9):1453–1459.
 118. Quijano-Roy S, Mbieleu B, Bönnemann CG, et al. De novo LMNA 
mutations cause a new form of congenital muscular dystrophy. Ann 
Neurol. 2008;64(2):177–186.
 119. De Sandre-Giovannoli A, Chaouch M, Kozlov S, et al.  Homozygous 
defects in LMNA, encoding lamin A/C nuclear-envelope pro-
teins, cause autosomal recessive axonal neuropathy in human 
 (Charcot-Marie-Tooth disorder type 2) and mouse. Am J Hum Genet. 
2002;70(3):726–736.
 120. Navarro CL, De Sandre-Giovannoli A, Bernard R, et al. Lamin A 
and ZMPSTE24 (FACE-1) defects cause nuclear disorganization and 
identify restrictive dermopathy as a lethal neonatal laminopathy. Hum 
Mol Genet. 2004;13(20):2493–2503.
 121. Cao H, Hegele RA. Nuclear lamin A/C R482Q mutation in Canadian 
kindreds with Dunnigan-type familial partial lipodystrophy. Hum Mol 
Genet. 2000;9(1):109–112.
 122. Shackleton S, Lloyd DJ, Jackson SN, et al. LMNA, encoding lamin A/C, 
is mutated in partial lipodystrophy. Nat Genet. 2000;24(2):153–156.
 123. Emery AE, Dreifuss FE. Unusual type of benign x-linked muscular 
dystrophy. J Neurol Neurosurg Psychiatry. 1966;29(4):338–342.
Cell Health and Cytoskeleton 2015:7submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
68
Meinke et al
 124. Bacon PA, Smith B. Familial muscular dystrophy of late onset. J Neurol 
Neurosurg Psychiatry. 1971;34(1):93–97.
 125. Levitas A, Muhammad E, Harel G, et al. Familial neonatal isolated car-
diomyopathy caused by a mutation in the flavoprotein subunit of suc-
cinate dehydrogenase. Eur J Hum Genet. 2010;18(10):1160–1165.
 126. Schirmer EC, Foisner R. Proteins that associate with lamins: many 
faces, many functions. Exp Cell Res. 2007;313(10):2167–2179.
 127. Meinke P, Mattioli E, Haque F, et al. Muscular dystrophy-associated 
SUN1 and SUN2 variants disrupt nuclear-cytoskeletal connections 
and myonuclear organization. PLoS Genet. 2014;10(9):e1004605.
 128. Liang WC, Mitsuhashi H, Keduka E, et al. TMEM43 mutations in 
Emery-Dreifuss muscular dystrophy-related myopathy. Ann Neurol. 
2011;69(6):1005–1013.
 129. Bione S, Maestrini E, Rivella S, et al. Identification of a novel X-linked 
gene responsible for Emery-Dreifuss muscular dystrophy. Nat Genet. 
1994;8(4):323–327.
 130. Zhang Q, Bethmann C, Worth NF, et al. Nesprin-1 and -2 are involved 
in the pathogenesis of Emery Dreifuss muscular dystrophy and are 
critical for nuclear envelope integrity. Hum Mol Genet. 2007;16(23): 
2816–2833.
 131. Clements L, Manilal S, Love DR, Morris GE. Direct interaction 
between emerin and lamin A. Biochem Biophys Res Commun. 
2000;267(3):709–714.
 132. Wiesel N, Mattout A, Melcer S, et al. Laminopathic mutations interfere 
with the assembly, localization, and dynamics of nuclear lamins. Proc 
Natl Acad Sci U S A. 2008;105(1):180–185.
 133. Melcon G, Kozlov S, Cutler DA, et al. Loss of emerin at the nuclear 
envelope disrupts the Rb1/E2F and MyoD pathways during muscle 
regeneration. Hum Mol Genet. 2006;15(4):637–651.
 134. Mattout A, Pike BL, Towbin BD, et al. An EDMD mutation in 
C. elegans lamin blocks muscle-specif ic gene relocation and 
 compromises muscle integrity. Curr Biol. 2011;21(19):1603–1614.
 135. Li P, Meinke P, Huong Le TT, Wehnert M, Noegel AA. Contribution 
of SUN1 mutations to the pathomechanism in muscular dystrophies. 
Hum Mutat. 2014;35(4):452–461.
 136. Taranum S, Vaylann E, Meinke P, et al. LINC complex alterations 
in DMD and EDMD/CMT fibroblasts. Eur J Cell Biol. 2012;91(8): 
614–628.
 137. Muntoni F, Bonne G, Goldfarb LG, et al. Disease severity in dominant 
Emery Dreifuss is increased by mutations in both emerin and desmin 
proteins. Brain. 2006;129(pt 5):1260–1268.
 138. Gundesli H, Talim B, Korkusuz P, et al. Mutation in exon 1f of PLEC, 
leading to disruption of plectin isoform 1f, causes autosomal-recessive 
limb-girdle muscular dystrophy. Am J Hum Genet. 2010;87(6): 
834–841.
 139. Cetin N, Balci-Hayta B, Gundesli H, et al. A novel desmin muta-
tion leading to autosomal recessive limb-girdle muscular dystrophy: 
distinct histopathological outcomes compared with desminopathies. 
J Med Genet. 2013;50(7):437–443.
 140. Hackman P, Vihola A, Haravuori H, et al. Tibial muscular dystrophy 
is a titinopathy caused by mutations in TTN, the gene encoding the 
giant skeletal-muscle protein titin. Am J Hum Genet. 2002;71(3): 
492–500.
 141. Hayashi YK, Chou FL, Engvall E, et al. Mutations in the integrin alpha7 
gene cause congenital myopathy. Nat Genet. 1998;19(1):94–97.
 142. Hoffmann K, Dreger CK, Olins AL, et al. Mutations in the gene 
encoding the lamin B receptor produce an altered nuclear morphol-
ogy in granulocytes (Pelger-Huet anomaly). Nat Genet. 2002;31(4): 
410–414.
 143. Olins AL, Hoang TV, Zwerger M, et al. The LINC-less granulocyte 
nucleus. Eur J Cell Biol. 2009;88(4):203–214.
 144. Horn HF, Brownstein Z, Lenz DR, et al. The LINC complex is essential 
for hearing. J Clin Invest. 2013;123(2):740–750.
 145. Muchir A, Shan J, Bonne G, Lehnart SE, Worman HJ. Inhibition of 
extracellular signal-regulated kinase signaling to prevent cardiomyo-
pathy caused by mutation in the gene encoding A-type lamins. Hum 
Mol Genet. 2009;18(2):241–247.
 146. Muchir A, Pavlidis P, Decostre V, et al. Activation of MAPK path-
ways links LMNA mutations to cardiomyopathy in Emery-Dreifuss 
muscular dystrophy. J Clin Invest. 2007;117(5):1282–1293.
 147. Eriksson M, Brown WT, Gordon LB, et al. Recurrent de novo point 
mutations in lamin A cause Hutchinson-Gilford progeria syndrome. 
Nature. 2003;423(6937):293–298.
 148. De Sandre-Giovannoli A, Bernard R, Cau P, et al. Lamin a truncation 
in Hutchinson-Gilford progeria. Science. 2003;300(5628):17.
 149. Agarwal AK, Fryns JP, Auchus RJ, Garg A. Zinc metalloproteinase, 
ZMPSTE24, is mutated in mandibuloacral dysplasia. Hum Mol Genet. 
2003;12(16):1995–2001.
 150. Hennekam RC. Hutchinson-Gilford progeria syndrome: review of the 
phenotype. Am J Med Genet A. 2006;140(23):2603–2624.
 151. Liu B, Wang J, Chan KM, et al. Genomic instability in laminopathy-
based premature aging. Nat Med. 2005;11(7):780–785.
 152. Musich PR, Zou Y. Genomic instability and DNA damage responses 
in progeria arising from defective maturation of prelamin A. Aging 
(Albany N Y). 2009;1(1):28–37.
 153. Gonzalez-Suarez I, Redwood AB, Perkins SM, et al. Novel roles for 
A-type lamins in telomere biology and the DNA damage response 
pathway. EMBO J. 2009;28(16):2414–2427.
 154. Puente XS, Quesada V, Osorio FG, et al. Exome sequencing and func-
tional analysis identifies BANF1 mutation as the cause of a hereditary 
progeroid syndrome. Am J Hum Genet. 2011;88(5):650–656.
 155. Madej-Pilarczyk A, Kmieć T, Fidziańska A, et al. Progeria caused by 
a rare LMNA mutation p.S143F associated with mild myopathy and 
atrial fibrillation. Eur J Paediatr Neurol. 2008;12(5):427–430.
 156. Starke S, Meinke P, Camozzi D, et al. Progeroid laminopathy with 
restrictive dermopathy-like features caused by an isodisomic LMNA 
mutation p.R435C. Aging. 2013;5(6):445–459.
 157. Padiath QS, Saigoh K, Schiffmann R, et al. Lamin B1 duplications 
cause autosomal dominant leukodystrophy. Nat Genet. 2006;38(10): 
1114–1123.
 158. Hegele RA, Cao H, Liu DM, et al. Sequencing of the reannotated 
LMNB2 gene reveals novel mutations in patients with acquired partial 
lipodystrophy. Am J Hum Genet. 2006;79(2):383–389.
 159. Kuzmina SN, Buldyaeva TV, Akopov SB, Zbarsky IB. Protein patterns 
of the nuclear matrix in differently proliferating and malignant cells. 
Mol Cell Biochem. 1984;58(1–2):183–186.
 160. Broers JL, Ramaekers FC. The role of the nuclear lamina in cancer 
and apoptosis. Adv Exp Med Biol. 2014;773:27–48.
 161. Neumann S, Noegel AA. Nesprins in cell stability and migration. 
Adv Exp Med Biol. 2014;773:491–504.
 162. Hutchison CJ. Do lamins influence disease progression in cancer? 
Adv Exp Med Biol. 2014;773:593–604.
 163. Daniele N, Richard I, Bartoli M. Ins and outs of therapy in limb 
girdle muscular dystrophies. Int J Biochem Cell Biol. 2007;39(9): 
1608–1624.
 164. Scharner J, Gnocchi VF, Ellis JA, Zammit PS. Genotype-phenotype 
correlations in laminopathies: how does fate translate? Biochem Soc 
Trans. 2010;38(pt 1):257–262.
 165. Wu W, Muchir A, Shan J, Bonne G, Worman HJ. Mitogen-activated 
protein kinase inhibitors improve heart function and prevent fibrosis 
in cardiomyopathy caused by mutation in lamin A/C gene. Circulation. 
2011;123(1):53–61.
 166. Muchir A, Kim YJ, Reilly SA, Wu W, Choi JC, Worman HJ. Inhibition 
of extracellular signal-regulated kinase 1/2 signaling has beneficial 
effects on skeletal muscle in a mouse model of Emery-Dreifuss mus-
cular dystrophy caused by lamin A/C gene mutation. Skelet Muscle. 
2013;3(1):17.
 167. Gordon LB, Kleinman ME, Miller DT, et al. Clinical trial of a 
farnesyltransferase inhibitor in children with Hutchinson-Gilford 
progeria syndrome. Proc Natl Acad Sci U S A. 2012;109(41): 
16666–16671.
 168. Larrieu D, Britton S, Demir M, Rodriguez R, Jackson SP. Chemical 
inhibition of NAT10 corrects defects of laminopathic cells. Science. 
2014;344(6183):527–532.
Cell Health and Cytoskeleton
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/cell-health-and-cytoskeleton-journal
Cell Health and Cytoskeleton is an international, peer-reviewed open 
access journal focusing on all aspects of cell structure and function 
contributing to normal physiology and cell health and exploring the 
pathogenesis of cell dysfunction leading to adverse conditions and disease 
in the organism. The journal welcomes papers covering original research, 
basic science, reviews and evaluations, guidelines, expert opinion and 
commentary, case reports and extended reports. The manuscript manage-
ment system is completely online and includes a very quick and fair peer-
review system, which is all easy to use. Visit http://www.dovepress.com/ 
testimonials.php to read real quotes from published authors.
Cell Health and Cytoskeleton 2015:7 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
69
Nucleoskeleton dynamics and functions in health and disease
 169. Swift J, Ivanovska IL, Buxboim A, et al. Nuclear lamin-A scales with 
tissue stiffness and enhances matrix-directed differentiation. Science. 
2013;341(6149):1240104.
 170. Raffaele Di Barletta M, Ricci E, Galluzzi G, et al. Different mutations 
in the LMNA gene cause autosomal dominant and autosomal recessive 
Emery-Dreifuss muscular dystrophy. Am J Hum Genet. 2000;66(4): 
1407–1412.
 171. Fatkin D, MacRae C, Sasaki T, et al. Missense mutations in the rod 
domain of the lamin A/C gene as causes of dilated cardiomyopa-
thy and conduction-system disease. N Engl J Med. 1999;341(23): 
1715–1724.
 172. Renou L, Stora S, Yaou RB, et al. Heart-hand syndrome of  Slovenian 
type: a new kind of laminopathy. J Med Genet. 2008;45(10): 
666–671.
 173. Chen L, Lee L, Kudlow BA, et al. LMNA mutations in atypical 
Werner’s syndrome. Lancet. 2003;362(9382):440–445.
 174. Novelli G, Muchir A, Sangiuolo F, et al. Mandibuloacral dysplasia 
is caused by a mutation in LMNA-encoding lamin A/C. Am J Hum 
Genet. 2002;71(2):426–431.
 175. Waterham HR, Koster J, Mooyer P, et al. Autosomal recessive HEM/
Greenberg skeletal dysplasia is caused by 3 beta-hydroxysterol delta 
14-reductase deficiency due to mutations in the lamin B receptor gene. 
Am J Hum Genet. 2003;72(4):1013–1017.
 176. Gros-Louis F, Dupré N, Dion P, et al. Mutations in SYNE1 lead to 
a newly discovered form of autosomal recessive cerebellar ataxia. 
Nat Genet. 2007;39(1):80–85.
 177. Hellemans J, Preobrazhenska O, Willaert A, et al. Loss-of-function 
mutations in LEMD3 result in osteopoikilosis, Buschke-Ollendorff 
syndrome and melorheostosis. Nat Genet. 2004;36(11):1213–1218.
 178. Debeer P, Pykels E, Lammens J, Devriendt K, Fryns JP. Melorheostosis 
in a family with autosomal dominant osteopoikilosis: report of a third 
family. Am J Med Genet A. 2003;1(2):188–193.
 179. Merner ND, Hodgkinson KA, Haywood AF, et al. Arrhythmogenic 
right ventricular cardiomyopathy type 5 is a fully penetrant, lethal 
arrhythmic disorder caused by a missense mutation in the TMEM43 
gene. Am J Hum Genet. 2008;82(4):809–821.
 180. Kayman-Kurekci G, Talim B, Korkusuz P, et al. Mutation in 
TOR1AIP1 encoding LAP1B in a form of muscular dystrophy: 
a novel gene related to nuclear envelopathies. Neuromuscul Disord. 
2014;24(7):624–633.
 181. Taylor MR, Slavov D, Gajewski A, et al; Familial Cardiomyopathy 
Registry Research Group. Thymopoietin (lamina-associated polypep-
tide 2) gene mutation associated with dilated cardiomyopathy. Hum 
Mutat. 2005;26(6):566–574.
 182. Ichida F, Tsubata S, Bowles KR, et al. Novel gene mutations in patients 
with left ventricular noncompaction or Barth syndrome. Circulation. 
2001;103(9):1256–1263.
